Sebacia

Sebacia, Inc. is a private medical device company dedicated to creating breakthrough topical therapies for skin conditions that affect millions of people. Sebacia's goal is to provide a better alternative to the daily use of currently available topical and systemic drugs for treating acne. Sebacia's patented microparticle technology was invented at Rice University, and the proprietary dermatological application was further developed by researchers at the Wellman Center for Photomedicine at Massachusetts General Hospital.